Covid-19 Situation in Europe
WHO warns Europe once again at epicentre of pandemic. The WHO Regional Office for Europe issued a statement on the 23rd, stating that the average daily number of COVID-19 deaths in the European region in the past week was close to 4,200, which was double the figure at the end of September. So far, the cumulative number of deaths from the COVID-19 in 53 countries in the region has exceeded 1.5 million.
WHO/Europe believes that the main reasons for the current epidemic situation in the region include: the highly infectious Delta strain has become the main virus spreading in the region; some countries believe that the COVID-19 epidemic is no longer an "emergency threat". The "mask order" and the maintenance of social distancing and other epidemic prevention measures have been lifted; as the weather becomes colder, people are spending more time indoors; many people have not yet been vaccinated, and vaccine effectiveness against infection gradually declines over time.

The Shortage of Testing and the Advantages of Antigen Tests
Many European countries are now grappling with shortages of coronavirus-testing as the daily coronavirus cases keep rising and hit record high. While PCR testing capacity is limited, rapid antigen detection tests are now widely used across Europe.
Compared with PCR, antigen tests can provide rapid and reliable result in just 15 minutes. Rapid antigen tests can greatly reduce transmission through early detection of highly infectious cases, pre-symptomatic and early symptomatic cases up to five days from symptom onset and help with isolation and contact tracing.
For antigen tests, you don’t need to go to a clinic or wait days for results. Just go to a local pharmacy whenever you want, swab your nose and read result in 15 minutes.
Antigen Test is Now Valid Proof for Entering Europe
Europe is now cautiously opening its border. Requiring travellers to present a negative COVID-19 test result is now the most normal thing when entering European countries as every country is trying to control the pandemic and protect their people.
Belgium is one of the European Union Member States that just recently announced that the country now accepts rapid antigen tests as valid proof for entry. A lot of popular EU destinations including Germany, Switzerland, Czechia, Poland, France, Netherlands, Portugal, Spain, Italy, Iceland and Greece also accept rapid antigen tests.
However, the validity of test result differs in different countries.
What Singclean is Doing Now?

Singclean is now ramp up production to over 6 million per week to meet rising demand of antigen testing worldwide. Our CE approved antigen tests including self-testing nasal swab, antigen swab, nasopharyngeal swab are being exported to many places which are hardest hit by Coronavirus, like Germany, Czech Republic, Lithuania, Greece and Thailand to aid in the early diagnosis of COVID-19 and help stop Covid-19 transmission rapidly.
We want to contribute to the fight against Covid-19 pandemic and we are doing it right now! Broader availability of rapid antigen test, together with high vaccination rates to establish herd immunity, could help end the pandemic soon.
-
singclean | 2021-11-26
Singclean’s Medical Sodium Hyaluronate Gel for Bone Joint Gained EU MDR CE Certification, Ranking Among First 3 Globally! 协合医疗骨科医用透明质酸钠凝胶成功斩获欧盟MDR CE认证!跻身全球前三!This achievement sets multiple industry records: it is the first MDR CE certificate for hyaluronic acid-based orthopedic products ever issued by DNV worldwide. Singclean Medical has become the first Chinese company to obtain such certification in this category and has successfully ranked among the first 3 companies globally to secure a viscosupplementation MDR CE certificate. This accomplishment underscores Singclean Medical's technological expertise and international competitiveness in the field of orthopedic biomaterials and hyaluronic acid applications. 此次认证创造了多项行业纪录:这是DNV在全球范围内签发的首张透明质酸骨科类MDR CE证书;协合医疗为中国首家获此证书的企业,更成功跻身全球前三。这一成绩,充分彰显了协合医疗在骨科生物医用材料及透明质酸领域的技术积累与国际竞争力。 -
singclean | 2021-11-26
Singclean Medical’s 2nd International Aesthetic Medicine Leadership Summit Concludes Successfully in Shanghai Shanghai, August 27, 2026 – The 2nd International Aesthetic Medicine Leadership Summit, hosted by Singclean Medical, was held at W Shanghai – The Bund, within the IMCAS China Congress venue. Under the theme “Global Vision, Opening a New Chapter,” the summit served as a cross‑border, multi‑disciplinary platform for professional exchange, gathering an impressive lineup of leading physicians and global partners. -
singclean | 2021-11-26
Singclean Medical to Showcase Innovative Aesthetic and Medical Solutions at Dubai Derma 2026 and Medical Fair Asia 2026HANGZHOU, China – Hangzhou Singclean Medical Products Co., Ltd., a leading innovator in absorbable biomaterials and medical aesthetic solutions, has announced its participation in two major international exhibitions in September 2026: Dubai Derma 2026 in the United Arab Emirates and Medical Fair Asia 2026 in Singapore.